KNOWLEDGE BANK

Interviews

Innovation Management at Bachem

Chief Technology Officer, Bachem Holding AG
Gnther Loidl joined Bachem in He held several functions in Research and Development RD and Active Pharmaceutical Ingredient Manufacturing and became Vice President RD in Since he is CTO of the Bachem Group and a member of the Corporate Executive Committee He studied chemistry in Regensburg Germany and Leeds UK and obtained his doctorate under the supervision of Luis Moroder at the Max Planck In...

Articles

Advancing Automation and Digitalization in the Industrial Microbiology Workflow

Industrial microbiology is a critical function in the biopharmaceutical sector as its purpose is to monitor for contamination events and inform development of standard operating procedures to minimize the risk of contamination As the industry makes the shift to digitalized labs you will see more automation digitalization

Research Insights

SARS-CoV-2 Omicron Variations Reveal Mechanisms Controlling Cell Entry Dynamics and Antibody Neutralization

Severe Acute Respiratory Syndrome Coronavirus SARSCoV is adapting to continuous presence in humans Transitions to endemic infection patterns are associated with changes in the spike S proteins that direct viruscell entry These changes generate antigenic drift and thereby allow virus maintenance in the face of prevalent human antiviral antibodies

Case Studies

Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer

This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive products For More Infromation Click Here

Techno Trends

New Antibiotic by Merck that Fights Bacteria

In the present drug discovery scenario there are very few pharmaceutical companies who invest in research into antibiotics as majority prefer to focus on profitable drugs for chronic diseases Most drugs were developed years ago and older antibiotics have lost their effect as the bacteria have become resistant to them Merck has developed an antibiotic platensim

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

QSAR - Changing the Landscape of Antidiabetic Drug Discovery

Smriti Sharma

Smriti Sharma Bhatia is an associate professor of chemistry at Miranda House, University of Delhi, India.  Her academic and research interests include Computational chemistry and drug design. Currently, her research group is focused on the design of oral drug formulations for Type 2 diabetes mellitus. She is a popular science communicator.

 

2

Green Synthesis of Metallic Nanoparticles

Ms. Aishwarya Jain

Ms. Aishwarya Jain is a distinguished pharmaceutical scientist and academician with over six years of experience in pharmaceutical sciences. Currently serving as an Assistant Professor at Sinhgad College of Pharmacy, Vadgaon (Bk), Pune, she has carved a niche for herself in the domains of nanotechnology, green synthesis, and pharmaceutical innovation.

A recipient of 65+ prestigious national and international awards, including the Bharat Shiksha Gaurav Puraskar and the Women Empowerment Award, Ms. Jain is recognised as one of the leading voices in pharmaceutical education and research. Her scholarly contributions span numerous books, book chapters, and high-impact research articles published in top-tier journals indexed in SCOPUS and Web of Science.

Renowned for her commitment to academic excellence and research integrity, she also plays an active role as an editorial board member and peer reviewer for reputed scientific journals and publishing houses. Her work exemplifies a seamless blend of academic rigor and innovative thinking, particularly in green nanotechnology and sustainable drug development.

Driven by a vision to advance pharmaceutical science for global health impact, Ms. Aishwarya continues to inspire through her interdisciplinary collaborations, cutting-edge research, and passionate teaching.

3

The Potential of Cell Free Chromatin Inhibition in Cancer

Divya S Mishra

Divya Mishra is a board certified oncologist with over 17 years’ experience in the pharmaceutical/CRO industry, clinical practice, and academia, in areas of oncology/haematology, family medicine, palliative medicine, and outcomes research. Mishra has worked across multiple geographies and diverse, multicultural settings for organisations such as Pfizer, IQVIA, and SFJ. She is currently working at ICON as a medical director and therapeutic expert for the oncology/haematology disease areas in the APAC region, based in the regional headquarters in Singapore.

 

4

Determinants of Antimicrobial Resistance (AMR) Research in South East Asia

Raja Chakraverty

Raja Chakraverty is a serving Scientist with the Indian Council of Medical Research with a decade long research and teaching career in Pharmaceutical Sciences with 54 publications (186 citations) and a book

 

Tatini Debnath

Doctoral Scholar, Department of Pharmaceutical Technology

5

Endocrine Disrupting Compounds (EDCs)

Sintu Kumar Samanta

Sintu Kumar Samanta has been working as an Assistant professor in IIIT Allahabad, India. He did Ph.D. and post-doctoral research from IIT Kharagpur and IISc Bangalore, India respectively. He is working in the area of Biochemistry and Nanobiotechnology. He published research work in several international journals and filed one Indian patent.

 

 
Pavan Kumar Gautam

Pavan Kumar Gautamis presently working as a Post-Doctoral Fellow in the Department of Applied Sciences at IIIT Allahabad, India. He obtained Ph.D. from the University of Allahabad, India. His area of research is synthesis of nanoparticles for water remediation. He published his research work in many international journals.

 

press releasesRead more...

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum

CiSparc Ltd Nasdaq SPRC Company or SciSparc today announced that NeuroThera Labs Inc TSXV NTLX NeuroThera a clinicalstage pharmaceutical company focused on developing novel treatments

RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer

RenovoRx Inc a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath a novel FDAcleared drugdelivery device today announced that the US Food and Drug Administratio

Alkem reports record high EBITDA, strong revenue growth in Q4 & FY26

Alkem Laboratories Ltd today announced its standalone and consolidated financial results for the fourth quarter ended March The Board of Directors took record of these results at its meeting held in Mumbai today

Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention

Curevo Vaccine Curevo a clinicalstage biotechnology company dedicated to developing varicella zoster virus VZV vaccines with improved tolerability today announced entry into a definitive agreement to be acquired by Lilly

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure

Biocytogen today announced the launch of RenSuper Workstation a nextgeneration AIpowered antibody discovery platform providing offtheshelf access to a largescale experimentally validated library

LimmaTech Biologics to be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections

LimmaTech Biologics AG a Swiss clinicalstage biotech company developing vaccines for the prevention of lifethreatening diseases today announced entry into a definitive agreement to be acquired by Lilly

EventsRead more...

01 - 02

Jun 2026

Future Pharma 2026

Renaissance Seaport District, Boston, MA, USA

02 - 04

Jun 2026

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia, USA

04 - 05

Jun 2026

Pharmac South 2026

Chennai Trade Centre, Nandambakkam, India

04 - 05

Jun 2026

09 - 11

Jun 2026

5th World ADC Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World TPD & Induced Proximity Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World Targeted Therapeutics Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 10

Jun 2026

ChemE Show 2026

George R. Brown Convention Center, Houston, Texas, USA

LATEST NEWSRead more...

Ionis Partner GSK Reports Positive Phase 3 Results for Bepirovirsen in Chronic Hepatitis B

Ionis Pharmaceuticals partner GSK has announced positive pivotal results for bepirovirsen an investigational antisense oligonucleotide ASO being developed for chronic hepatitis B CHB Findings from the Phase BWell

Pfizer and Innovent Biologics Sign Global Collaboration to Advance Oncology Pipeline

Pfizer and Innovent Biologics have entered into a global strategic licensing and collaboration agreement to support the research and development of earlystage cancer medicines The partnership covers antibodydrug conjugates

Insilico Medicine and Human Longevity Partner to Develop AI Foundation Model for Longevity Science

Insilico Medicine and Human Longevity have announced a multimilliondollar collaboration to develop what they describe as the industrys first largescale AI foundation model focused on longevity science

Merz Therapeutics Enters into Agreement with Jiangxi Kvvit Pharmaceutical for INBRIJA® in Parkinson’s Disease

Merz Therapeutics and Jiangxi Kvvit Pharmaceutical have signed an exclusive licence and collaboration agreement for INBRIJA levodopa inhalation powder in mainland China Hong Kong and Macao

AbbVie Receives Positive CHMP Opinion for MAVIRET in Acute Hepatitis C Treatment

AbbVie announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of MAVIRET for the treatment of acute hepatitis C virus HCV infection in adults and children aged three years and above

Gilead Sciences Receives Approval for Hepcludex as the Treatment for Chronic HDV

Gilead Sciences has announced that the US Food and Drug Administration FDA has granted accelerated approval to Hepcludex bulevirtidegmod mg for the treatment of adults living with chronic hepatitis delta virus HDV infection